Prothena Corp. Plc (PRTA)

9.82 +0.22 (+2.29%) USD  |  NASDAQ  |  Sep 04, 16:00
9.80 -0.02 (-0.20%) After-Hours: 20:00
More

Prothena SG&A Expense (TTM) : 49.45M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PRTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 49.45M
March 31, 2026 54.46M
December 31, 2025 59.39M
September 30, 2025 63.59M
June 30, 2025 67.12M
March 31, 2025 67.33M
December 31, 2024 67.20M
September 30, 2024 67.29M
June 30, 2024 67.18M
March 31, 2024 65.56M
December 31, 2023 61.84M
September 30, 2023 58.02M
June 30, 2023 53.36M
March 31, 2023 51.80M
December 31, 2022 49.90M
September 30, 2022 48.98M
June 30, 2022 48.95M
March 31, 2022 47.03M
December 31, 2021 46.32M
September 30, 2021 44.02M
June 30, 2021 41.46M
March 31, 2021 40.09M
December 31, 2020 38.70M
September 30, 2020 36.85M
June 30, 2020 36.15M
Date Value
March 31, 2020 35.57M
December 31, 2019 35.74M
September 30, 2019 35.70M
June 30, 2019 36.25M
March 31, 2019 38.16M
December 31, 2018 42.48M
September 30, 2018 48.50M
June 30, 2018 51.70M
March 31, 2018 51.62M
December 31, 2017 48.23M
September 30, 2017 43.79M
June 30, 2017 47.48M
March 31, 2017 44.71M
December 31, 2016 41.06M
September 30, 2016 38.08M
June 30, 2016 27.85M
March 31, 2016 25.24M
December 31, 2015 23.10M
September 30, 2015 21.49M
June 30, 2015 19.81M
March 31, 2015 19.23M
December 31, 2014 19.05M
September 30, 2014 19.31M
June 30, 2014 18.47M
March 31, 2014 16.74M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Alkermes Plc 841.17M
Amarin Corp. Plc 76.76M
Agenus, Inc. 38.48M
Amgen, Inc. 7.019B
Anika Therapeutics, Inc. 52.67M